HTG Molecular Diagnostics' IPO

HTG Molecular Diagnostics raised a round of funding on May 06, 2015. Investors include Public.

HTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that levera…

Articles about HTG Molecular Diagnostics' IPO: